SCHEMBL4423903

SCHEMBL4423903

CSc1nc(-c2cccc(O)c2)c2c(N)c(C(N)=O)ccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LHCGR P22888 6/20 0.54
PIK3CG P48736 4/20 0.41
TSHR P16473 1/20 0.41
BRAF P15056 2/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
PARP1 P09874 1/20 0.39
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PIK3CD O00329 2/20 0.37
PIK3CA P42336 2/20 0.37
PIK3CB P42338 2/20 0.37
PIK3C2B O00750 1/20 0.37
PDXK O00764 1/20 0.37
GAK O14976 1/20 0.37
MAP3K7 O43318 1/20 0.37
RIPK2 O43353 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4432379 0.90 LHCGR (0.43) LHCGRPIK3CGTSHRBRAFPDE4A
SCHEMBL4430421 0.88 LHCGR (0.66) LHCGRPIK3CGTSHRBRAFPDE4A
SCHEMBL4418728 0.86 LHCGR (0.57) LHCGRPIK3CGTSHRBRAFPDE4A
SCHEMBL4422529 0.81 JAK3 (0.42) LHCGRTSHRBRAFKMT2AFSHR
SCHEMBL4423221 0.81 LHCGR (0.41) LHCGRPIK3CGTSHRBRAFPDE4A
SCHEMBL4430425 0.80 LHCGR (0.52) LHCGRPIK3CGTSHRBRAFPDE4A
SCHEMBL4425074 0.80 LHCGR (0.45) LHCGRTSHRBRAFKMT2AFSHR
SCHEMBL4422167 0.78 LHCGR (0.55) LHCGRTSHRBRAFPDE4APDE4B
SCHEMBL4428948 0.78 LHCGR (0.52) LHCGRTSHRBRAFPDE4APDE4B
SCHEMBL4423898 0.78 LHCGR (0.55) LHCGRPIK3CGTSHRBRAFPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618963-B2 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2009-11-17 US disclosed
US-20070197527-A1 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2007-08-23 US disclosed
US-7229990-B2 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2007-06-12 US disclosed
US-20030225113-A1 Bicyclic heteroaromatic compounds MERCK SHARP & DOHME B.V. (NL) 2003-12-04 US disclosed
EP-1322651-A1 BICYCLIC HETEROAROMATIC COMPOUNDS Akzo Nobel N.V. (NL) 2003-07-02 EP disclosed
WO-2002024703-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AKZO NOBEL N.V. (NL) 2002-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225113-A1 Bicyclic heteroaromatic compounds NR5A1, CYP19A1, FSHR LHCGR 13/4885PIK3CG 2840/4885TSHR 1000/4885
US-20070197527-A1 Bicyclic heteroaromatic compounds NR5A1, CYP19A1, FSHR LHCGR 10/4885PIK3CG 2845/4885TSHR 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.